Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03250507 · ClinicalTrials.gov registry record · Phase 4
Mixture of Liposomal Bupivacaine and Bupivacaine for TAP Block for Open Hysterectomy
A Phase 4 study of Hysterectomy, sponsored by Henry Ford Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT03250507: Completed Phase 4 study of Hysterectomy, sponsored by Henry Ford Health System.
NCT03250507 is a Phase 4 study of Hysterectomy that has completed, run by Henry Ford Health System. The registered enrollment target is 90 participants, below the 128-participant average among 8 other Hysterectomy trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03250507, a Phase 4 study of Hysterectomy, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to evaluate the effectiveness of different formulations of bupivacaine infiltrated into the transversus abdominis plane (TAP) on post-operative pain management after open abdominal hysterectomy.
Primary Outcome
Total opioid consumption
Conditions Studied
Interventions
- DRUG Bupivacaine
- DRUG Saline
- DRUG Liposomal bupivacaine
Study Locations (1)
Michigan
- Henry Ford Hospital - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2017-03-13 |
| Est. Completion | 2019-01-30 |
| Phase | Phase 4 |
What the finished NCT03250507 record still lists
NCT03250507 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 128-participant average among 8 other Hysterectomy trials with a reported enrollment target (30% lower).
The record links to 1 condition, with Hysterectomy appearing as the primary indexed condition, and to 3 interventions - of which Bupivacaine is the first listed.
NCT03250507 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03250507 about?
NCT03250507 is a clinical study titled "Mixture of Liposomal Bupivacaine and Bupivacaine for TAP Block for Open Hysterectomy". The goal of this study is to evaluate the effectiveness of different formulations of bupivacaine infiltrated into the transversus abdominis plane (TAP) on post-operative pain management after open abdominal hysterectomy.
What is the current status of trial NCT03250507?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2017-03-13. Estimated completion is 2019-01-30.
What conditions does trial NCT03250507 study?
This clinical trial studies the following conditions: Hysterectomy.
What interventions are being tested in trial NCT03250507?
The interventions under investigation include: Bupivacaine (DRUG), Saline (DRUG), Liposomal bupivacaine (DRUG).
Who is sponsoring clinical trial NCT03250507?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03250507 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hysterectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03250507's enrollment target sits among peer trials
90 6th of 8 higher than 3 of 8 other Hysterectomy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hysterectomy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Vaginal Cuff Anesthesia and Post-Operative Pain Medication Use
RECRUITING · Phase 4
-
NAC vs Placebo on Opioid Use for Hysterectomy
RECRUITING · Phase 3
-
Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy
RECRUITING · Phase 3
-
Bilateral Oophorectomy Versus Ovarian Conservation
COMPLETED · NA
-
Ultravision Visual Clearing System in Laparoscopic Hysterectomy and Myomectomy
COMPLETED · NA
-
Urinary Tract Infections Rates Using 50% Dextrose Plus Washout Versus Normal Saline as Cystoscopy Fluid
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI